Published in J Clin Invest on August 01, 1994
Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest (1998) 1.72
The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest (1999) 1.71
Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J Clin Invest (1995) 1.36
The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? J Anat (2002) 1.35
Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med (2005) 1.35
Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax (2003) 0.97
Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice. Am J Pathol (2004) 0.90
Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung. Br J Pharmacol (1996) 0.85
Utility of large-animal models of BPD: chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol (2015) 0.85
Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome. Heart (2001) 0.79
Endogenous nitric oxide and pulmonary circulation response to hypoxia in high-altitude adapted Tibetan sheep. Eur J Appl Physiol (2004) 0.79
Pulmonary hypertension: NO therapy? Thorax (1996) 0.78
Effect of adenovirus-mediated gene transfer of nitric oxide synthase on vascular reactivity of rat isolated pulmonary arteries. Pflugers Arch (2006) 0.77
Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats. J Anesth (2015) 0.76
The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases. Glob Cardiol Sci Pract (2014) 0.76
Perinatal nitric oxide therapy prevents adverse effects of perinatal hypoxia on the adult pulmonary circulation. Biomed Res Int (2014) 0.75
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A (1987) 14.22
L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun (1988) 7.77
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71
Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med (1993) 6.22
Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest (1983) 6.05
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med (1986) 6.05
Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest (1989) 5.01
Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet (1992) 3.30
Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet (1992) 2.66
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation (1991) 2.62
Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med (1991) 2.45
Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet (1991) 2.30
Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest (1993) 2.14
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest (1992) 2.07
Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest (1991) 1.91
Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology (1993) 1.63
Inhaled nitric oxide in congenital heart disease. Circulation (1993) 1.26
Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. J Physiol (1993) 1.18
In vivo aortic muscle cell growth kinetics. Differences between thoracic and abdominal segments after intimal injury in the rabbit. Circ Res (1980) 1.17
Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology (1991) 1.15
Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis (1991) 1.13
Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J Clin Invest (1988) 1.12
Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists. Am Rev Respir Dis (1984) 1.06
Effects of exposure of blood hemoglobin to nitric oxide. Environ Res (1985) 1.05
EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. Am J Physiol (1993) 1.05
Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis (1993) 1.04
Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res (1992) 1.01
Nitrosyl-hemoglobin formation in the blood of animals exposed to nitric oxide. Arch Environ Health (1975) 0.98
Early recovery from hypoxic pulmonary hypertension: a structural and functional study. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.93
Effect of alpha-methyldopa on the pulmonary vascular changes induced by chronic hypoxia in rats. Clin Sci Mol Med (1977) 0.91
L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol (1992) 0.90
Polycythemia and the acute hypoxic response in awake rats following chronic hypoxia. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.89
Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia. J Clin Invest (1990) 0.87
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest (2001) 2.59
Mutations in the essential spindle checkpoint gene bub1 cause chromosome missegregation and fail to block apoptosis in Drosophila. J Cell Biol (1999) 2.41
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J (2005) 1.98
Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest (1991) 1.91
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation (2005) 1.84
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest (2000) 1.80
Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood (2001) 1.51
Muscle strength and body composition in adult women with Marfan syndrome. Rheumatology (Oxford) (2007) 1.47
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med (1995) 1.46
Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schönlein purpura. Preliminary results of a prospective uncontrolled trial. Nephron (1995) 1.45
5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol (2000) 1.42
Localization of the Drosophila checkpoint control protein Bub3 to the kinetochore requires Bub1 but not Zw10 or Rod. Chromosoma (1998) 1.41
Case 4-1993. Inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiothorac Vasc Anesth (1993) 1.39
Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res (1999) 1.37
Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J (2001) 1.26
Decreased VEGF concentration in lung tissue and vascular injury during ARDS. Eur Respir J (2005) 1.17
Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur Respir J (2001) 1.15
Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Am J Physiol (1997) 1.14
Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol (2000) 1.13
Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am J Respir Cell Mol Biol (2000) 1.12
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J (2006) 1.11
Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension. Eur Respir J (2009) 1.11
Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. Am J Physiol (1998) 1.10
Comparison of human bronchial muscle responses to histamine in vivo with histamine and isoproterenol agonists in vitro. Am Rev Respir Dis (1986) 1.07
High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. Ann Intern Med (1994) 1.02
Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency. Effects of indomethacin. Chest (1993) 1.02
Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats. Circ Res (2000) 1.01
Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. Am J Respir Cell Mol Biol (2000) 1.00
Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. Am J Respir Crit Care Med (2000) 1.00
Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig. J Pharmacol Exp Ther (1989) 1.00
Histamine contraction of isolated human airway muscle preparations: role of prostaglandins. J Pharmacol Exp Ther (1986) 1.00
Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine. Am Rev Respir Dis (1987) 0.99
Pathobiology of pulmonary arterial hypertension. Eur Respir J (2002) 0.99
Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am J Physiol (1995) 0.96
Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. J Pharmacol Exp Ther (2001) 0.95
Low molecular weight heparin fractions as an alternative therapy in heparin-induced thrombocytopenia. Haemostasis (1987) 0.95
Optimal handling of blood samples for routine measurement of lactate and pyruvate. Arch Pathol Lab Med (1994) 0.93
Haemodynamics and gas exchange before and after coil embolization of pulmonary arteriovenous malformations. Eur Respir J (1995) 0.92
Severe hypoxemia-associated intrapulmonary shunt in a patient with chronic liver disease: improvement after medical treatment. Am Rev Respir Dis (1992) 0.92
Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol (2007) 0.92
Acute and chronic respiratory effects of sulfur mustard intoxication in guinea pig. J Appl Physiol (1985) (1994) 0.92
Beta-adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy. Am Heart J (1992) 0.92
Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents. J Pharmacol Exp Ther (1985) 0.91
Protein kinase C influences rat pulmonary vascular reactivity. Am Rev Respir Dis (1990) 0.91
L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol (1992) 0.90
Human isolated bronchial muscle preparations from asthmatic patients: effects of indomethacin and contractile agonists. Prostaglandins (1989) 0.88
Effects of neuraminidase on airway reactivity in the guinea pig. Am Rev Respir Dis (1992) 0.87
Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia. Am J Respir Crit Care Med (1998) 0.87
Monitoring the fidelity of mitotic chromosome segregation by the spindle assembly checkpoint. Cell Prolif (2011) 0.87
Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig. Pharmacol Res Commun (1986) 0.86
Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injury. Am J Respir Crit Care Med (1997) 0.86
Matrix metalloproteinase gelatinases in sulfur mustard-induced acute airway injury in guinea pigs. Am J Physiol (1999) 0.85
Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Am J Physiol (1997) 0.85
Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. Am J Cardiol (1992) 0.85
Time course of muscular blood metabolites during forearm rhythmic exercise in hypoxia. J Appl Physiol (1985) (1986) 0.85
Cardiopulmonary and carotid baroreflex control of splanchnic and forearm circulations. Am J Physiol (1993) 0.83
Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology (1995) 0.83
NO in the lung. Respir Physiol (1995) 0.83
Loss of endothelium-dependent relaxation in proximal pulmonary arteries from rats exposed to chronic hypoxia: effects of in vivo and in vitro supplementation with L-arginine. J Cardiovasc Pharmacol (1993) 0.83
Cardiac and lung VEGF mRNA expression in chronically hypoxic and monocrotaline-treated rats. Chest (1998) 0.83
The serotonin pathway in pulmonary hypertension. Arch Mal Coeur Vaiss (2006) 0.82
Dilator effect of endothelins in pulmonary circulation: changes associated with chronic hypoxia. Am J Physiol (1993) 0.82